106 related articles for article (PubMed ID: 36029288)
1. Evaluating information loss in the National Cancer Database from cases lost to follow-up.
Cotler JH; Nogueira L; McCabe R; Nelson H; Brajcich BC; Boffa DJ; Lum SS; Harris JB; Hawhee V; Mullett TW; Bilimoria KY; Palis BE
J Surg Oncol; 2022 Nov; 126(6):1123-1132. PubMed ID: 36029288
[TBL] [Abstract][Full Text] [Related]
2. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
3. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
4. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
5. Childhood malignancies in the EUROCARE study: the database and the methods of survival analysis.
Magnani C; Gatta G; Corazziari I; Kramarova E; Pastore G; Viscomi S; Stiller C
Eur J Cancer; 2001 Apr; 37(6):678-86. PubMed ID: 11311641
[TBL] [Abstract][Full Text] [Related]
6. The clinical effectiveness and cost-effectiveness of different surveillance mammography regimens after the treatment for primary breast cancer: systematic reviews registry database analyses and economic evaluation.
Robertson C; Arcot Ragupathy SK; Boachie C; Dixon JM; Fraser C; Hernández R; Heys S; Jack W; Kerr GR; Lawrence G; MacLennan G; Maxwell A; McGregor J; Mowatt G; Pinder S; Ternent L; Thomas RE; Vale L; Wilson R; Zhu S; Gilbert FJ
Health Technol Assess; 2011 Sep; 15(34):v-vi, 1-322. PubMed ID: 21951942
[TBL] [Abstract][Full Text] [Related]
7. Long-term survival of women with breast cancer in New South Wales.
Taylor R; Davis P; Boyages J
Eur J Cancer; 2003 Jan; 39(2):215-22. PubMed ID: 12509954
[TBL] [Abstract][Full Text] [Related]
8. Trends in the survival of patients diagnosed with cancer in the Nordic countries 1964-2003 followed up to the end of 2006. Material and methods.
Engholm G; Gislum M; Bray F; Hakulinen T
Acta Oncol; 2010 Jun; 49(5):545-60. PubMed ID: 20491523
[TBL] [Abstract][Full Text] [Related]
9. Incident Cases Captured in the National Cancer Database Compared with Those in U.S. Population Based Central Cancer Registries in 2012-2014.
Mallin K; Browner A; Palis B; Gay G; McCabe R; Nogueira L; Yabroff R; Shulman L; Facktor M; Winchester DP; Nelson H
Ann Surg Oncol; 2019 Jun; 26(6):1604-1612. PubMed ID: 30737668
[TBL] [Abstract][Full Text] [Related]
10. Lifetime survival and medical costs of lung cancer: a semi-parametric estimation from South Korea.
Park HY; Hwang J; Kim DH; Jeon SM; Choi SH; Kwon JW
BMC Cancer; 2020 Sep; 20(1):846. PubMed ID: 32883237
[TBL] [Abstract][Full Text] [Related]
11. Impact of the Management and Proportion of Lost to Follow-Up Cases on Cancer Survival Estimates for Small Population-Based Cancer Registries.
Gil F; Miranda-Filho A; Uribe-Perez C; Arias-Ortiz NE; Yépez-Chamorro MC; Bravo LM; de Vries E
J Cancer Epidemiol; 2022; 2022():9068214. PubMed ID: 35140789
[TBL] [Abstract][Full Text] [Related]
12. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
Milano AF
J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
14. Twenty-Five Years of Cancer Follow-Up; Is the Data Worth the Effort?
Brajcich BC; Palis BE; McCabe R; Nogueira L; Boffa DJ; Lum SS; Harris JB; Hawhee V; Mullett TW; Bilimoria KY; Nelson H
Ann Surg Oncol; 2022 Feb; 29(2):828-836. PubMed ID: 34689251
[TBL] [Abstract][Full Text] [Related]
15. Building a database for survival analysis.
Guzzinati S; Vitarelli S; Ramazzotti V; Tumino R
Epidemiol Prev; 2001; 25(3 Suppl):15-20. PubMed ID: 11695195
[TBL] [Abstract][Full Text] [Related]
16. Estimation of Life-Year Loss and Lifetime Costs for Different Stages of Colon Adenocarcinoma in Taiwan.
Chen PC; Lee JC; Wang JD
PLoS One; 2015; 10(7):e0133755. PubMed ID: 26207912
[TBL] [Abstract][Full Text] [Related]
17. Reevaluation of lung cancer risk in the acrylonitrile cohort study of the National Cancer Institute and the National Institute for Occupational Safety and Health.
Marsh GM; Youk AO; Collins JJ
Scand J Work Environ Health; 2001 Feb; 27(1):5-13. PubMed ID: 11266147
[TBL] [Abstract][Full Text] [Related]
18. "Lost to Follow-up" Among Adult Cancer Survivors.
Gill A; Gosain R; Bhandari S; Gosain R; Gill G; Abraham J; Miller K
Am J Clin Oncol; 2018 Oct; 41(10):1024-1027. PubMed ID: 29028642
[TBL] [Abstract][Full Text] [Related]
19. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years.
Miller AB; Baines CJ; To T; Wall C
CMAJ; 1992 Nov; 147(10):1459-76. PubMed ID: 1423087
[TBL] [Abstract][Full Text] [Related]
20. Acute lymphoblastic leukemia: an assessment of international incidence, survival, and disease burden.
Katz AJ; Chia VM; Schoonen WM; Kelsh MA
Cancer Causes Control; 2015 Nov; 26(11):1627-42. PubMed ID: 26376890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
